18F –labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer
A novel radiotracer 1 ‑(2‑(2‑(2‑[18F]fluoroethoxy)ethoxy)ethyl)‑1H‑1,2,3‑triazole‑estradiol ([18F]FETE) was successfully synthesized, characterized and evaluated in mice for estrogen receptor (ER)-positive breast cancer targeting with positron emission tomography (PET) imaging.
Source: Nuclear Medicine and Biology - Category: Nuclear Medicine Authors: Duo Xu, Rongqiang Zhuang, Linyi You, Zhide Guo, Xiangyu Wang, Chenyu Peng, Deliang Zhang, Pu Zhang, Hua Wu, Weimin Pan, Xianzhong Zhang Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Estradiol | Nuclear Medicine | PET Scan